BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15362597)

  • 1. Refractory hypoglycemia from ciprofloxacin and glyburide interaction.
    Lin G; Hays DP; Spillane L
    J Toxicol Clin Toxicol; 2004; 42(3):295-7. PubMed ID: 15362597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glyburide-ciprofloxacin interaction with resistant hypoglycemia.
    Roberge RJ; Kaplan R; Frank R; Fore C
    Ann Emerg Med; 2000 Aug; 36(2):160-163. PubMed ID: 10918110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "refractory hypoglycemia from ciprofloxacin and glyburide interaction".
    Roberge R
    Clin Toxicol (Phila); 2005; 43(3):213-4. PubMed ID: 15902799
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged hypoglycemic crisis associated with glyburide.
    Sills MN; Ogu CC; Maxa J
    Pharmacotherapy; 1997; 17(6):1338-40. PubMed ID: 9399622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas.
    Parekh TM; Raji M; Lin YL; Tan A; Kuo YF; Goodwin JS
    JAMA Intern Med; 2014 Oct; 174(10):1605-12. PubMed ID: 25179404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide.
    Schelleman H; Bilker WB; Brensinger CM; Wan F; Hennessy S
    Clin Pharmacol Ther; 2010 Aug; 88(2):214-22. PubMed ID: 20592722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide therapy for recurrent refractory hypoglycemia due to sulfonylurea in diabetes-related kidney failure.
    Gonzalez RR; Zweig S; Rao J; Block R; Greene LW
    Endocr Pract; 2007; 13(4):417-23. PubMed ID: 17669721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
    Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
    JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coadministration of co-trimoxazole with sulfonylureas: hypoglycemia events and pattern of use.
    Tan A; Holmes HM; Kuo YF; Raji MA; Goodwin JS
    J Gerontol A Biol Sci Med Sci; 2015 Feb; 70(2):247-54. PubMed ID: 24858839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia.
    Barkin JA; Block HM; Mendez PE
    Pancreas; 2013 May; 42(4):722-3. PubMed ID: 23591434
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus.
    Fonseca VA; Kelley DE; Cefalu W; Baron MA; Purkayastha D; Nestler JE; Hsia S; Gerich JE
    Metabolism; 2004 Oct; 53(10):1331-5. PubMed ID: 15375790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide.
    Clemens KK; McArthur E; Dixon SN; Fleet JL; Hramiak I; Garg AX
    Can J Diabetes; 2015 Aug; 39(4):308-16. PubMed ID: 25840942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect.
    Kelesidis T; Canseco E
    Am J Med; 2010 Feb; 123(2):e5-6. PubMed ID: 20103009
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy.
    LeBlanc M; BĂ©langer C; Cossette P
    Pharmacotherapy; 2004 Jul; 24(7):926-31. PubMed ID: 15303456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.
    Sobieraj DM; Freyer CW
    Ann Pharmacother; 2010; 44(7-8):1334-7. PubMed ID: 20516361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting sulfonylureas -- long-acting hypoglycaemia.
    Veitch PC; Clifton-Bligh RJ
    Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe hypoglycemia from clarithromycin-repaglinide drug interaction.
    Khamaisi M; Leitersdorf E
    Pharmacotherapy; 2008 May; 28(5):682-4. PubMed ID: 18447665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents.
    Menzies DJ; Dorsainvil PA; Cunha BA; Johnson DH
    Am J Med; 2002 Aug; 113(3):232-4. PubMed ID: 12208383
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoglycemia in glyburide-treated gestational diabetes: is it dose-dependent?
    Brustman L; Langer O; Scarpelli S; El Daouk M; Fuchs A; Rosenn B
    Obstet Gynecol; 2011 Feb; 117(2 Pt 1):349-353. PubMed ID: 21252749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hypoglycemia associated with levofloxacin in Type 2 diabetic patients receiving polytherapy: two case reports.
    Micheli L; Sbrilli M; Nencini C
    Int J Clin Pharmacol Ther; 2012 Apr; 50(4):302-6. PubMed ID: 22456302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.